Cargando…

ESBLs: A Clear and Present Danger?

Extended spectrum β-lactamases (ESBLs) are enzymes produced by a variety of Gram negative bacteria which confer an increased resistance to commonly used antibiotics. They are a worrying global public health issue as infections caused by such enzyme-producing organisms are associated with a higher mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhillon, Rishi H.-P., Clark, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135063/
https://www.ncbi.nlm.nih.gov/pubmed/21766013
http://dx.doi.org/10.1155/2012/625170
_version_ 1782208051166576640
author Dhillon, Rishi H.-P.
Clark, John
author_facet Dhillon, Rishi H.-P.
Clark, John
author_sort Dhillon, Rishi H.-P.
collection PubMed
description Extended spectrum β-lactamases (ESBLs) are enzymes produced by a variety of Gram negative bacteria which confer an increased resistance to commonly used antibiotics. They are a worrying global public health issue as infections caused by such enzyme-producing organisms are associated with a higher morbidity and mortality and greater fiscal burden. Coupled with increasing prevalence rates worldwide and an ever diminishing supply in the antibiotic armamentarium, these enzymes represent a clear and present danger to public health. This article aims to give an overview of the current situation regarding ESBLs, with a focus on the epidemiology and management of such infections.
format Online
Article
Text
id pubmed-3135063
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-31350632011-07-15 ESBLs: A Clear and Present Danger? Dhillon, Rishi H.-P. Clark, John Crit Care Res Pract Review Article Extended spectrum β-lactamases (ESBLs) are enzymes produced by a variety of Gram negative bacteria which confer an increased resistance to commonly used antibiotics. They are a worrying global public health issue as infections caused by such enzyme-producing organisms are associated with a higher morbidity and mortality and greater fiscal burden. Coupled with increasing prevalence rates worldwide and an ever diminishing supply in the antibiotic armamentarium, these enzymes represent a clear and present danger to public health. This article aims to give an overview of the current situation regarding ESBLs, with a focus on the epidemiology and management of such infections. Hindawi Publishing Corporation 2012 2011-06-06 /pmc/articles/PMC3135063/ /pubmed/21766013 http://dx.doi.org/10.1155/2012/625170 Text en Copyright © 2012 R. H.-P. Dhillon and J. Clark. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Dhillon, Rishi H.-P.
Clark, John
ESBLs: A Clear and Present Danger?
title ESBLs: A Clear and Present Danger?
title_full ESBLs: A Clear and Present Danger?
title_fullStr ESBLs: A Clear and Present Danger?
title_full_unstemmed ESBLs: A Clear and Present Danger?
title_short ESBLs: A Clear and Present Danger?
title_sort esbls: a clear and present danger?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135063/
https://www.ncbi.nlm.nih.gov/pubmed/21766013
http://dx.doi.org/10.1155/2012/625170
work_keys_str_mv AT dhillonrishihp esblsaclearandpresentdanger
AT clarkjohn esblsaclearandpresentdanger